Prof Garry Duffy
Investigator



T +353 (0)91 495 943
E garry.duffy@nuigalway.ie

Garry Duffy is a graduate in Anatomy from the National University of Ireland, Galway (2002). His PhD was in the area of adult stem cell therapeutics for cardiovascular disease under the supervision of Prof. Frank Barry in the Regenerative Medicine Institute (REMEDI) in NUIG. He is a two-time Fulbright Scholar. In 2006 he was awarded a scholarship to carry out research in cardiovascular tissue engineering and stem cell biology at the Georgia Institute of Technology under the supervision of Prof. Robert M. Nerem. His second Fulbright Scholarship was awarded in 2013 to carry out research in advanced materials for cardiac regeneration at Brigham and Women’s Hospital and Harvard Medical School in collaboration with Prof. Jeffrey Karp.

He is currently Personal Professor of Anatomy at NUI Galway and leads the Duffy Lab within the School of Medicine. He is also Honorary Professor of Regenerative Medicine at the Royal College of Surgeons in Ireland and a PI in the Tissue Engineering Research Group. His current research focuses on advanced biomaterial and cell based therapies for chronic disease and is funded by Enterprise Ireland, Science Foundation Ireland and the European Union’s FP7 and Horizon 2020 programmes. He was appointed as Principal Investigator in the Trinity Centre for Bioengineering in November 2009. Prof. Duffy’s work in AMBER is under the Biomaterials Platform where he will continue to develop novel biomaterial carriers for delivery of cell based therapeutics to treat cardiovascular disease and diabetes.

Website: www.duffykellylabs.ie

Staff

  • Claire McKenna
  • Denise Carthy
  • Keith Alden
  • Dr Lorraine Byrne
  • Deirdre Caden
  • Brian Callagy
  • James Doyle
  • Dr Colm Faulkner
  • Dr Rachel Kavanagh
  • Colm McAtamney
  • Cathal McAuley
profile

Claire McKenna
AMBER Funding Manager
T +353 (0)1 896 4642
E claire.mckenna@tcd.ie

profile

Denise Carthy
Business Development Manager
T +353 (0)1 896 4642
E denise.carthy@tcd.ie

profile

Keith Alden
Business Development Manager
T +353 (0)1 896 3485
E keith.alden@tcd.ie

profile

Dr Lorraine Byrne
Executive Director
T +353 (0)1 896 4130
E lorraine.byrne@tcd.ie

profile

Deirdre Caden
AMBER Funding Manager
T +353 (0)1 896 3403
E deirdre.caden@tcd.ie

profile

Brian Callagy
IP Contracts & Commercialisation Manager
T +353 (0)1 896 3032
E brian.callagy@tcd.ie

profile

James Doyle
Project Manager
T +353 (0)1 896 4838
E james.doyle@tcd.ie

profile

Dr Colm Faulkner
Business Development Executive
T +353 (0)1 896 4170
E cfaulkne@tcd.ie

profile

Dr Rachel Kavanagh
Education and Public Engagement Officer
T +353 (0)1 896 4621
E kavanara@tcd.ie

profile

Colm McAtamney
AMBER General Manager
T +353 (0)1 896 3092
E colm.mcatamney@tcd.ie

profile

Cathal McAuley
AML Operations Manager
T +353 (0)1 896 4933
E cathal.mcauley@tcd.ie

Vacancies

  • 3D printing of fibrous electroconductive biomaterials with controlled architectures for peripheral n
  • Tissue-derived Bioinks for 3D Printing Applications- Material Characterisation, Biocompatibility and
  • Postdoctoral Researcher in 3D Bioprinting and Tissue Engineering
profile

3D printing of fibrous electroconductive biomaterials with controlled architectures for peripheral n

3D printing of fibrous electroconductive biomaterials with controlled architectures for peripheral nerve repair

The position will be based with the Buckley Lab (www.buckleylab.eu) within the Advanced Materials and Bioengineering Research (AMBER) centre. Prof. Buckley leads a multidisciplinary research group in the Trinity Centre for Biomedical Engineering at Trinity College Dublin. The goal of the Buckley lab is to develop novel biomaterial and cell-based strategies to regenerate or repair damaged tissues to restore function using minimally invasive strategies (MIS).

Summary of project

Peripheral nerve injury remains a major clinical problem. Autografts are the current ‘gold standard’ but are hampered by limited availability of donor tissue with poor prognosis for functional recovery at both the donor and recipient sites. As a result, new approaches are currently being investigated to develop artificial nerve grafts which mimic the properties of autologous grafts. Additive manufacturing (AM) techniques such as 3D bioprinting (3DBP) offers exciting new opportunities and horizons to engineer nerve guidance conduits (NGCs) that more closely match the composition and structure of native nerve tissue. These approaches facilitate precise control over the external and internal microarchitecture geometry. In the context of developing engineered nerve tissue AM offers the added ability to incorporate drug delivery systems with tailorable spatial and temporal release profiles of individual drugs. Similarly, following peripheral nerve injury, the transfer of electrical signals across a damaged nerve is inhibited, resulting in degeneration of the distal nerve segment. Printing offers the potential to create specific geometries with defined micropatterns as well as incorporating electroconductive biomaterials to provide direct electrical activation to enhance tissue repair, enhance cell function and alignment. Applying electrical stimuli may enhance the regeneration as it is known that inhibition of electrical signalling can impede normal tissue function. Using bioinks derived from native nerve as a biomaterial platform developed in the Buckley lab for peripheral nerve tissue regeneration, this project proposes to enhance regenerative capacity of NGCs through the incorporation of electroconductive materials from partner labs in AMBER (e.g. graphene, silver nanowires, polypyrrole). Such a conductive biomaterial could thus provide direct electrical activation of isolated regions while also providing a scaffolding template to enhance the tissue repair process. Following optimisation of the fabrication/printing process, in vitro biocompatibility of the biofabricated NGCs and the response of cells to electrical stimuli will be assessed using in vitro methods prior to pre-clinical assessment. For more information please contact Prof. Conor Buckley conor.buckley@tcd.ie


Download PDF of vacancy details.
profile

Tissue-derived Bioinks for 3D Printing Applications- Material Characterisation, Biocompatibility and

Tissue-derived Bioinks for 3D Printing Applications- Material Characterisation, Biocompatibility and Immunomodulatory Behaviour

Project Description: This project is part of multidisciplinary team that is exploring the use of emerging 3D Printing and 3D Bioprinting strategies for Tissue Engineering and the development of next generation medical devices. The project is part of the AMBER centre (http://ambercentre.ie) and located primarily at dedicated bioprinting and additive manufacturing laboratories based in Trinity College Dublin. With the advent of 3D printing in tissue engineering, the advantages of precise deposition and highly defined geometric patterning 3D biomaterial structures that it offers, efforts have been made to combine the benefits of ECM hydrogels with this technology. However, many of the existing ECM bioinks lack the necessary physiologically relevant mechanical properties, e.g. compressive strength, especially for application to high load environments in musculoskeletal, or high wear environments such as the cardiovascular system. Other drawbacks include slow thermogelation times, hindering printing speeds, and rapid degradation times, limiting their potential active therapeutic window for in vivo applications. Further chemical functionalisation of the ECM through the incorporation of photoactive moieties to the collagen fibre backbone allows for light polymerised photogelation, increased polymer network crosslinking, and improved tuning of material properties. To this end, we are developing a range of photoactive ECM shear thinning hydrogels, which can be used as injectable therapeutics or as bioinks for 3D bioprinting applications. This approach aims to combine the intrinsic regenerative potential of ECM and engineering precision of 3D printing, with distinct improvements in material and mechanical properties. In addition, understanding how these bioinks influence macrophage phenotype is important for in vivo applications. Engineering an appropriate immune response is integral to successful tissue regeneration given its importance to clearing damaged cells and tissue, recruiting host stem cells and inducing vascularization. For more information please contact Prof. Conor Buckley conor.buckley@tcd.ie

Applicant criteria: The ideal applicant will have a PhD in biomedical engineering, biomaterials, tissue engineering, biochemistry and immunology or a related discipline. Previous experience in 3D printing, hydrogels, tissue engineering, cell culture, gene expression, biochemical analysis, mechanical testing, histology techniques, immunomodulatory behaviour would be highly advantageous. Excellent written and oral communication skills are essential. An excellent publication record and/or development of intellectual property would be advantageous.
How to apply: CVs with the names and addresses of three referees should be submitted via email to Prof. Conor Buckley conor.buckley@tcd.ie with the subject heading “AMBER-Bioink Postdoc”. Positions will remain opened until filled but preferred start date is January 2021. Only short-listed applications will be acknowledged.


Download PDF of vacancy details.
profile

Postdoctoral Researcher in 3D Bioprinting and Tissue Engineering

The development of novel additive biomanufacturing strategies to tissue engineer hybrid implants for synovial joint regeneration

Project Description: The successful applicant will join a multidisciplinary team that is exploring the use of emerging 3D bioprinting strategies for Tissue Engineering and the development of next generation medical devices. The overall goal of the project is to develop a new class of 3D bioprinted biological implant that will regenerate, rather than replace, diseased joints. This will be realised by integrating developments in the 3D printing of metals, biodegradable polymers and cell-laden bioinks to develop hybrid biological devices, using dedicated bioprinting and additive manufacturing laboratories based in Trinity College Dublin. The successful applicant will specifically focus on integrating 3D printed metal implants with tissue engineered articular cartilage to develop hybrid implants for resurfacing the hip joint. The overall project is a collaboration between the Advanced Materials and Bioengineering Research (AMBER) centre, DePuy Ireland Unlimited Company and Johnson & Johnson Services, Inc.

For more information please contact Prof. Daniel Kelly (kellyd9@tcd.ie).

Applicant criteria: The ideal applicant will have a PhD in biomaterials, tissue engineering, 3D printing or a related subject. Previous experience in 3D (bio)printing, hydrogels, tissue engineering, cell culture, biochemical analysis, mechanical testing, histology techniques would be highly advantageous. Excellent written and oral communication skills are essential.

Start Date: From January 2021 onwards; position will remain open until it is filled.

How to apply: CVs with the names and contact details of three referees should be submitted via email to Prof. Daniel Kelly (kellyd9@tcd.ie).


Download PDF of vacancy details.